IP Verse

Combination Therapy Comprising Sglt Inhibitors And Dpp4 Inhibitors - EP2252289

PATENT ANALYSIS

Patent Details

Grant Date
Oct 23, 2019
Company
MITSUBISHI TANABE PHARMA CORPORATION
Oppositions

ELKINGTON AND FIFE LLP

More patents of Mitsubishi Tanabe Pharma Corporation

EP2896397

EP2252289

EP2754440

Want to monitor this patent?

Feel free to send us a message here and we will get back to you